Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Celularity Inc. - Class A Common Stock (NQ: CELU )

2.140 +0.090 (+4.39%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Celularity Inc. - Class A Common Stock

< Previous 1 2 3 4 5 Next >
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers Cellectar Biosciences (NASDAQ:CLRB 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Surrozen (NASDAQ:SRZN) stock rose 33.14% to $9.64 during Tuesday's regular session. The company's market cap stands at $351.2 million. ZIOPHARM Oncology (... 
Via Benzinga
14 SPACs That Palantir Technologies Has Invested In Or Partnered
Palantir Technologies Inc (NYSE: PLTR) is one of the most well-known publicly traded companies. The data analytics company is increasing its investments in the SPAC space,... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers Celularity (NASDAQ:CELU) shares rose 7.0% to $7.33 during Tuesday's after-market session. The market value of their outstanding shares is at $904.9... 
Via Benzinga
The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 16) Bio-Rad Laboratories, Inc... 
Via Benzinga
Market Briefing For Wednesday, July 21
Via Talk Markets
How Aging-Related Conditions Are Increasing The Treatment Burden For Older Patients
Via FinancialNewsMedia
Analyzing Celularity's Unusual Options Activity
Celularity (NASDAQ:CELU) shares experienced unusual options activity on Thursday. The stock price moved up to $10.34 following the option alert. Sentiment: BULLISH Option Type:... 
Via Benzinga
EXCLUSIVE: Celularity's CEO On 'One-Size-Fits-All' Product, Palantir Connection
Former PepsiCo Inc (NASDAQ: PEP) president and Apple Inc (NASDAQ: AAPL) CEO John Sculley raved about Celularity Inc (NASDAQ: CELU) Monday on Benzinga's YouTube... 
Via Benzinga
EXCLUSIVE: Former PepsiCo President And Apple CEO John Sculley Tells A Steve Jobs Story
John Sculley, former president of PepsiCo Inc (NASDAQ: PEP) and former CEO of Apple Inc (NASDAQ: AAPL), appeared on Benzinga's YouTube show "Power... 
Via Benzinga
The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 12) Adagio Therapeutics, Inc. (... 
Via Benzinga
Exposures Product Safety
77 Biggest Movers From Yesterday
Gainers Powerbridge Technologies Co., Ltd. (NASDAQ: PBTS) shares surged 65.4% to close at $2.10 on Thursday after the company announced it is expanding its blockchain business to... 
Via Benzinga
30 Stocks Moving In Monday's Mid-Day Session
Gainers Cytokinetics, Incorporated (NASDAQ: CYTK) jumped 56.4% to $30.07 after the company disclosed topline results from Cohorts 1 and 2 of REDWOOD-HCM. Aehr Test Systems (... 
Via Benzinga
The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 11) Adagio Therapeutics, Inc. (... 
Via Benzinga
Exposures Product Safety
61 Biggest Movers From Yesterday
Gainers Chembio Diagnostics, Inc. (NASDAQ: CEMI) shares surged 159.2% to close at $5.34 on Wednesday after the company received a $28.3 million purchase order from Brazil's... 
Via Benzinga
54 Biggest Movers From Yesterday
Gainers Aehr Test Systems (NASDAQ: AEHR) shares climbed 87.9% to close at $6.39 on Monday after the company won a $10.8 million single purchase order from its lead silicon... 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.